These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 21893696)
1. Effects of peroxisome proliferator-activated receptors-gamma ligands on dextran sodium sulphate-induced colitis in rats. Celinski K; Dworzanski T; Korolczuk A; Piasecki R; Slomka M; Madro A; Fornal R J Physiol Pharmacol; 2011 Jun; 62(3):347-56. PubMed ID: 21893696 [TBL] [Abstract][Full Text] [Related]
2. Influence of the peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist, rosiglitazone and antagonist, biphenol-A-diglicydyl ether (BADGE) on the course of inflammation in the experimental model of colitis in rats. Dworzanski T; Celinski K; Korolczuk A; Slomka M; Radej S; Czechowska G; Madro A; Cichoz-Lach H J Physiol Pharmacol; 2010 Dec; 61(6):683-93. PubMed ID: 21224499 [TBL] [Abstract][Full Text] [Related]
3. The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis. Ramakers JD; Verstege MI; Thuijls G; Te Velde AA; Mensink RP; Plat J J Clin Immunol; 2007 May; 27(3):275-83. PubMed ID: 17510806 [TBL] [Abstract][Full Text] [Related]
4. Comparison of anti-inflammatory properties of peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone in prophylactic treatment of experimental colitis. Celinski K; Dworzanski T; Fornal R; Korolczuk A; Madro A; Brzozowski T; Slomka M J Physiol Pharmacol; 2013 Oct; 64(5):587-95. PubMed ID: 24304573 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the anti-inflammatory and therapeutic actions of PPAR-gamma agonists rosiglitazone and troglitazone in experimental colitis. Celinski K; Dworzanski T; Fornal R; Korolczuk A; Madro A; Slomka M J Physiol Pharmacol; 2012 Dec; 63(6):631-40. PubMed ID: 23388479 [TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut. Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094 [TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats. Sánchez-Hidalgo M; Martín AR; Villegas I; de la Lastra CA Eur J Pharmacol; 2007 May; 562(3):247-58. PubMed ID: 17343846 [TBL] [Abstract][Full Text] [Related]
8. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats. Sánchez-Hidalgo M; Martín AR; Villegas I; Alarcón De La Lastra C Biochem Pharmacol; 2005 Jun; 69(12):1733-44. PubMed ID: 15876425 [TBL] [Abstract][Full Text] [Related]
9. Expression of peroxisome proliferator-activated receptor-gamma in macrophage suppresses experimentally induced colitis. Shah YM; Morimura K; Gonzalez FJ Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G657-66. PubMed ID: 17095756 [TBL] [Abstract][Full Text] [Related]
10. Activated and inactivated PPARs-γ modulate experimentally induced colitis in rats. Celinski K; Dworzanski T; Korolczuk A; Slomka M; Radej S; Cichoz-Lach H; Madro A Med Sci Monit; 2011 Apr; 17(4):BR116-24. PubMed ID: 21455100 [TBL] [Abstract][Full Text] [Related]
11. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism. Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073 [TBL] [Abstract][Full Text] [Related]
12. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia. Liu D; Zeng BX; Zhang SH; Yao SL Inflamm Res; 2005 Nov; 54(11):464-70. PubMed ID: 16307220 [TBL] [Abstract][Full Text] [Related]
13. Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines. Zwolinska-Wcislo M; Krzysiek-Maczka G; Ptak-Belowska A; Karczewska E; Pajdo R; Sliwowski Z; Urbanczyk K; Drozdowicz D; Konturek SJ; Pawlik WW; Brzozowski T J Physiol Pharmacol; 2011 Jun; 62(3):357-68. PubMed ID: 21893697 [TBL] [Abstract][Full Text] [Related]
14. Activation of peroxisome proliferator-activated receptor-gamma potentiates pro-inflammatory cytokine production, and adrenal and somatotropic changes of weaned pigs after Escherichia coli lipopolysaccharide challenge. Liu Y; Shi J; Lu J; Meng G; Zhu H; Hou Y; Yin Y; Zhao S; Ding B Innate Immun; 2009 Jun; 15(3):169-78. PubMed ID: 19474210 [TBL] [Abstract][Full Text] [Related]
15. Reduction of peroxisome proliferation-activated receptor gamma expression by gamma-irradiation as a mechanism contributing to inflammatory response in rat colon: modulation by the 5-aminosalicylic acid agonist. Linard C; Grémy O; Benderitter M J Pharmacol Exp Ther; 2008 Mar; 324(3):911-20. PubMed ID: 18077625 [TBL] [Abstract][Full Text] [Related]
16. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats. Liu DS; Liu WJ; Chen L; Ou XM; Wang T; Feng YL; Zhang SF; Xu D; Chen YJ; Wen FQ Toxicology; 2009 Jun; 260(1-3):112-9. PubMed ID: 19464576 [TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease. Adachi M; Kurotani R; Morimura K; Shah Y; Sanford M; Madison BB; Gumucio DL; Marin HE; Peters JM; Young HA; Gonzalez FJ Gut; 2006 Aug; 55(8):1104-13. PubMed ID: 16547072 [TBL] [Abstract][Full Text] [Related]
18. Involvement of glucocorticoid receptor and peroxisome proliferator activated receptor-gamma in pioglitazone mediated chronic gastric ulcer healing in rats. Lahiri S; Sen T; Palit G Eur J Pharmacol; 2009 May; 609(1-3):118-25. PubMed ID: 19281808 [TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, protects against gastric ischemia-reperfusion damage in rats: role of oxygen free radicals generation. Villegas I; Martín AR; Toma W; de la Lastra CA Eur J Pharmacol; 2004 Nov; 505(1-3):195-203. PubMed ID: 15556153 [TBL] [Abstract][Full Text] [Related]
20. Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat. Houdeau E; Moriez R; Leveque M; Salvador-Cartier C; Waget A; Leng L; Bueno L; Bucala R; Fioramonti J Gastroenterology; 2007 Mar; 132(3):982-93. PubMed ID: 17324399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]